MOUD Training

View  MOUD Training Schedule 

Sponsorship
The Providers Clinical Support System-Medications for Opioid Use Disorders (PCSS-MOUD) is a program funded by the Substance Abuse and Mental Health Services Administration (SAMHSA) and created in response to the opioid overdose epidemic. PCSS-MOUD’s goal is to provide evidence-based practices to improve healthcare and outcomes in the prevention of those at risk and treatment for individuals with an opioid use disorder (OUD).

PCSS-MOUD is led by the American Academy of Addiction Psychiatry (AAAP) in collaboration with AOAAM and an extensive coalition of national professional and healthcare organizations. PCSS-MOUD provides multidisciplinary training, guidance, mentorship, and implementation support at no cost to healthcare and behavioral health professionals to identify and treat their patients using U.S. Food and Drug Administration-approved (FDA) medications for opioid use disorder (MOUD). The overarching goal of PCSS-MOUD is to increase healthcare professionals’ knowledge, skills, and confidence in providing evidence-based practices in the prevention, treatment, recovery, and harm reduction of OUD.

Program Overview
A 4.25-hour live webcast session, consisting of modules, case studies and a q&a session. The training focuses on specifics of treating patients with opioid use disorders in office-based settings and clinical vignettes to help trainees think through “real life” experiences in opioid use disorders treatment.
1A AOA CME and AAFP CME is offered and sponsored by the AOAAM for this session.

This training will count towards the DEA’s new 8-hour training

requirement when applying for or renewing your DEA license.

Section 1262 of the Consolidated Appropriations Act, 2023 (also known as Omnibus bill), removes the federal requirement for practitioners to submit a Notice of Intent and obtain a waiver to your DEA license to prescribe schedule III-V medications, approved by the FDA for the treatment of opioid use disorder (OUD).

The Consolidated Appropriations Act of 2023 enacted a new one-time, eight-hour training requirement for all Drug Enforcement Administration (DEA)-registered practitioners on the treatment and management of patients with opioid or other substance use disorders.

Beginning on June 27, 2023, practitioners will be required to check a box on their online DEA registration form, affirming that they have completed the new training requirement.

Program Goals and Objectives

PCSS-MOUD aims to increase the knowledge and skills of healthcare and counseling professionals about available evidence-based treatment approaches for substance use disorder (SUD) with a particular focus on opioid use disorder (OUD). PCSS-MOUD provides free training and mentoring to practitioners on the use of medications for OUD (MOUD) and the integration of these services into mainstream health care.

PCSS-MOUD maintains and expands a comprehensive repository of training materials and educational resources to support evidence-based treatment of opioid use disorder. This repository includes an 8-hour MOUD course that meets the Drug Enforcement Administration (DEA) training requirement for prescribers to obtain or renew their DEA License Registration. In addition, PCSS-MOUD provides tailored education, training, mentorship consultation, and implementation support to multidisciplinary primary and specialty healthcare providers on team-based MOUD and general approaches for OUD screening, treatment, recovery, and harm reduction.

For More Information and FREE training and educational resources on MOUD visit pcssNOW.org.

Review Course
Register Now

 AOAAM Online CME

Non-members interested in CME must create a profile with AOAAM. Subscribe now or Join Us to receive the full benefits of membership.

Latest News  read more

Did you miss us at OMED?

Now Available On-Demand